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acceptable reliability and good validity, which could be used to assess angina 
self-management, and also recommended to be used as an outcome along with 
quality of life to assess clinical efficacy. The risk-factor domain would be 
modified in the further study.  
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1Affiliated Hospital of Liaoning University of Traditional Chinese Medicine, Shenyang, China, 
2Liaoning University of Traditional Chinese Medicine, Shenyang, China  
OBJECTIVES: Fatigue is the main symptom of anemia. A blood transfusion is 
often necessary in patients with severe anemia, and fatigue will be released after 
the transfusion. However, patients with chronic anemia are often well tolerated, 
and do not feel the severe fatigue that is expected. So, how much is fatigue 
associated with anemia, and what’s the main impact influencing anemic 
fatigue? METHODS: Patients diagnosed with CAA or MDS-RA were recruited in 
an undergoing prospective observational study. Fatigue was assessed by the 
FACIT-Fatigue scale, and a higher score means better quality of life. All the 
patients filled in the Fatigue scale and ran blood tests on the day enrolled, and 
they were encouraged to be assessed by both Fatigue scale and blood test again a 
week later. The patients were divided into groups based on transfusion-
dependent, transfusion treatment, anemia level (severe<65g/L), fatigue level 
(severe<30). Chi-square or T-tests were performed between different groups. 
Pearson correlations were tested to investigate association between fatigue and 
all the possible factors. RESULTS: Thirty-eight patients (54±18 years, 12 male) 
enrolled, of those, 20 were transfusion-dependent, 14 had severe anemia, and 26 
felt severe fatigue. The anemia history was 54±78 months (median 15). 
Transfusion-dependent patients showed no difference in fatigue. Severe anemia 
patients (22±11) reported more fatigue than non-severe (27±11), but no difference 
(p=0.199). Twenty patients agreed to the reassessment; of those, 12 got 
transfusion treatment. After transfusion, the mean Hb level increased (11±8 g/L), 
and fatigue improved (8±10); as for the non-transfusion group, Hb changed (-4±13 
g/L), and fatigue changed (0±16). However, there was no difference between the 
two groups (p>0.05). Anemia history was related with fatigue (r=-0.351, p=0.031) 
and transfusion frequency (r=-0.617, p=0.001). CONCLUSIONS: Fatigue is not 
closely associated with degree of Hb and is well tolerated in chronic anemia 
patient. RBC transfusion can relieve fatigue, but a large sample is needed to 
confirm it.  
 
PRM170  
DO ASIANS HAVE SIMILAR HEALTH-STATE PREFERENCE? A STUDY OF 
MAINLAND CHINESE AND SINGAPOREANS  
Wang P, Luo N 
National University of Singapore, Singapore, Singapore  
OBJECTIVES: To compare the preference values for EQ-5D-5L health states 
between mainland Chinese and Singaporeans. METHODS: Data was from a 
multi-country health-state valuation study in which the preference values for 10 
selected EQ-5D-5L health states were elicited from a convenience sample of 
mainland Chinese in Beijing (China) as well as a convenience sample of 
Singaporeans. Each participant self-completed 5 time trade-off (TTO) tasks, each 
for a different EQ-5D-5L state, using a personal computer. The difference in TTO 
values between mainland Chinese and Singaporeans and three subgroups of 
Singaporeans (i.e. English-speaking Chinese [EC], Chinese-speaking Chinese [CC], 
and non-Chinese [NC]) was analyzed using random-effects linear regression and 
logistic regression models. RESULTS: A total of 210 mainland Chinese and 207 
Singaporeans provided data for this study. All 10 EQ-5D-5L health states 
considered, Singaporeans’ preference value was 0.146 points lower than that of 
mainland Chinese and the difference was consistent for all three subgroups of 
Singaporeans (EC: -0.156; CC: -0.195; NC: -0.073; p>0.05 for all comparisons), 
suggesting those health states were less valuable to Singaporeans than to 
mainland Chinese. Compare to mainland Chinese, Singaporeans were more 
likely to consider a health state as worse than being dead and consequently have 
a negative value to the state; the odds ratio (95% confidence interval) was 
1.31(0.54-3.53) for Singaporeans as a whole, 1.41(0.60-3.33) for EC, 1.35(0.49-3.70) 
for CC, and 1.11(0.50-3.13) for NC. For health states rated as worse than being 
dead, Singaporeans had substantial lower preference values than mainland 
Chinese, with the magnitude of difference being 0.399 for all, 0.383 for EC, 0.377 
for CC, and 0.456 for NC (P<0.05 for all comparisons). CONCLUSIONS: It appears 
that health-state preferences differ between mainland Chinese and 
Singaporeans including Singaporean Chinese. Our study supports the practice of 
developing country-specific value sets for EQ-5D-5L health states.  
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COGNITIVE TESTING OF THE INVESTIGATOR'S GLOBAL ASSESSMENT OF 
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OBJECTIVES: To evaluate clinicians’ ability to understand and respond to the 
IGA-LCL, a single item severity rating scale of LCLs at neutral facial position. 
METHODS: Individual face-to-face cognitive interviews were conducted with 
seven dermatologists and one plastic surgeon from the US with experience in 
aesthetic medicine including treating LCLs. Participants attended one of two 
research sessions. At each session, the participant group received training on the 
IGA-LCL, consistent with the training provided for clinicians in phase 3 trials 
using the IGA-LCL. Two researchers then conducted individual semi-structured 
interviews with participants, following a process that required them to “think 
aloud” while reading response options and formulating a response. Interviews 
were audio-recorded and transcribed. Analyses summarized participant 
feedback on the instrument. RESULTS: Overall, findings indicate that the IGA-
LCL scale is clear and easy to use. Clinicians understood the content and were 
able to use the response options as intended. No revisions to the IGA-LCL scale 
were recommended based on results from this study, though training topics 
were identified for further emphasis and clarification. A few participants 
suggested alternate text for some response descriptions though these same 
participants understood and could use the descriptions as currently stated. One 
participant noted that she might arbitrarily define the descriptions differently 
based on her clinical experience and noted the subjectivity in making a clinical 
judgment of LCL severity, but understood and could use the IGA-LCL 
appropriately based on the training. Two participants indicated that they usually 
think about the “worst” length of wrinkle, but they could rate “average” length as 
instructed in the training. Most participants stressed the importance of training 
for proper use of the scale. CONCLUSIONS: Results support the content validity 
of the IGA-LCL. This research represents an important step toward establishing 
the content validity of the IGA-LCL relative to the FDA PRO Guidance.  
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DESIGNING CORRESPONDING ASSESSMENTS FOR CHILDREN AND PARENTS TO 
IMPROVE DATA CAPTURE IN SPECIAL POPULATIONS  
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OBJECTIVES: To describe the qualitative development of corresponding self-
reported and observer reported scales for assessing spasticity-related pain (SRP) 
experienced by children with Cerebral Palsy (CP). METHODS: The Questionnaire 
on Pain Caused by Spasticity (QPS) is a newly developed clinical outcome 
measure designed to assess SRP using corresponding versions that can be self-
administered by children (5-10 years), adolescents (11-17 years), and by parent 
caregivers (as observers of signs of pain in their children). Cognitive interviews 
were conducted to confirm appropriate understanding and the ability of children 
of various ages and CP severity to provide meaningful responses. RESULTS: Two 
children, eight adolescents, and 11 parent/caregivers participated in the 
interview sessions. Parent/caregivers were able to work with their children to 
collectively identify the location of their SRP. Children age 7 and above who 
could read and had sufficient motor skills for independently self-administering a 
questionnaire could answer questions about pain severity in relation to specific 
activities, but were not able to reliably address the frequency or duration of their 
pain. Children 5-7 years (and those with more severe CP) who were able to 
communicate answered the same items but in interviewer-administered format. 
Parent/caregivers could report on observed signs of pain in their children but not 
address the subjective intensity of that pain. They could, however, report on the 
frequency of those signs of pain. Because direct attention and close contact time 
between parent/caregivers and children with CP varies, parent/caregiver 
observations of the duration of pain was less reliable. CONCLUSIONS: Direct 
correspondence of items addressing key concepts (e.g. presence of SRP) can 
provide an anchor for combining patient reported and observer reported 
information and relating the various descriptive aspects around the concepts 
being measured to provide a more complete and richer dataset for compromised 
populations where assessment is challenging.  
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THE PAIN ASSESSMENT FOR LOWER BACK SYMPTOMS (PAL-S): QUALITATIVE 
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OBJECTIVES: To develop a patient-reported outcome (PRO) measure to assess the 
key symptoms of chronic low back pain (cLBP) through qualitative concept 
elicitation (CE) and cognitive interviews. METHODS: Adult patients (18-80 years) 
with clinical diagnoses of cLBP of non-malignant origin and current pain scores 
≥4 on a 0-10 numerical rating scale (NRS) were recruited in the U.S., UK, and 
Germany. Trained interviewers conducted CE and cognitive interview sessions 
with participating patients using semi-structured interview guides. The CE 
interviews elicited spontaneous reports of symptom experiences followed by 
probing to further explore and confirm concepts. The cognitive interviews 
evaluated the degree of patient comprehension of the items in the draft PRO 
measure. All interview sessions were audio recorded and transcribed. The CE 
interviews were coded for qualitative content analysis using Atlas.ti, and the 
cognitive interview transcripts were summarized in cognitive report tables. 
RESULTS: Forty-three CE interviews were conducted (mean age: 48.6±13.0, 53.5% 
female, 74.4% -White/Caucasian). Mean pain NRS score was 6.7± 1.3. A total of 
1342 symptom codes were derived from the transcripts, representing 32 different 
symptom concepts. Data from CE interviews was considered alongside existing 
measures, published literature and expert opinion to develop a 23-item draft 
measure. Thirty additional patients participated in four waves of cognitive 
interviews, during which nine items were removed and others were 
substantially modified to create the Pain Assessment for Low Back Symptoms 
(PAL-S). CONCLUSIONS: The PAL-S is a 14-item PRO measure for assessing 
symptoms of cLBP that has been developed through direct qualitative patient 
involvement in accordance with the FDA’s PRO Guidance and scientific best 
practices. Cognitive interviews have provided evidence from patients that the 
measure is comprehensive, relevant to their cLBP experience, comprehendible, 
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and easy to complete. The measure will be further tested in additional 
qualitative and quantitative studies to evaluate its measurement properties.  
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METHODOLOGICAL REPORTING CHECKLIST  
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OBJECTIVES: There has been a growing interest in developing country-specific 
scoring algorithms for the EQ-5D around the world. This study systematically 
reviews all existing EQ-5D valuation studies to highlight their strengths and 
limitations, explores heterogeneity in observed utilities using meta-regression, 
and proposes a methodological checklist, the Checklist for Valuation Studies of 
the EQ-5D (CREATE) for reporting EQ-5D valuation studies. METHODS: We 
searched Medline, EMBASE, the National Health Service Economic Evaluation 
Database (NHS EED) via Wiley’s Cochrane Library, and Wiley’s Health Economic 
Evaluation Database from inception through November 2012, as well as 
bibliographies of key papers and the EuroQol Plenary Meeting Proceedings from 
1991 to 2012 for English-language reports of EQ-5D valuation studies. Two 
reviewers independently screened the titles and abstracts for relevance. Three 
reviewers performed data extraction and compared the characteristics and 
scoring algorithms developed in the included valuation studies. RESULTS: Of the 
31 studies included in the review, 19 used the time trade-off (TTO) technique, 10 
used the visual analogue scale (VAS) technique, and 2 used both TTO and VAS. 
Most studies used respondents from the general population selected by random 
or quota sampling, and face-to-face interviews or postal surveys. Studies valued 
between 7 and 198 total states, with 1 to 23 states valued per respondent. 
Different model specifications have been proposed for scoring. Some sample or 
demographic factors, including gender, education, per cent urban population, 
and national health care expenditure were associated with differences in 
observed utilities for moderate or severe health states. CONCLUSIONS: EQ-5D 
valuation studies conducted to date have varied widely in their design and in the 
resulting scoring algorithms. Therefore, we propose the CREATE for those 
conducting valuation studies.  
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CLINICAL OUTCOME ASSESSMENTS AND RATER TRAINING MATERIALS - 
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OBJECTIVES: Consistency between translated clinical outcome assessments and 
corresponding rater training documentation is critical for global clinical trials. If 
the translation of rater training materials is completed independently or without 
reference to the linguistically validated clinical outcomes assessments, 
inconsistencies between the scale and the rater training materials are created. 
Steps must be taken to ensure consistency between rater training materials and 
their corresponding scales. METHODS: A review of prior projects involving rater 
training materials and corresponding scales, as well as discussion with Sponsors 
who have conducted translations with other organizations was conducted to 
provide insight into key areas where reference between the translation of the 
clinical outcomes assessment and the rater training material proved critical. 
RESULTS: Reviews of prior projects revealed that early reference to previously 
translated scales yielded improved linguistic consistencies between overlapping 
text found in rater training documentation, as well as yielding time efficiencies. 
If the rater training documentation was translated independently of the scale, 
inconsistencies existed between the scale and the rater training materials. This 
required additional reconciliation efforts, adding both timeline and cost to the 
project scope to rectify the inconsistencies. By centralizing the translation 
process for these documents, the inconsistencies were eliminated, and the 
additional cost and timeline for a secondary reconciliation process was avoided. 
CONCLUSIONS: It is important that the content used to train raters is consistent 
with the actual scale they will be using. If the translations are completed without 
reference to the scale, there will be inconsistent text that could ultimately 
confuse the rater and generate inaccurate results. Centralization of the rater 
training material translations and scale translations, or providing the translation 
provider completing the rater training documentation with the relevant scale 
translations for reference before project initiation, maximizes consistency 
between clinical outcome assessment translations and their corresponding rater 
training documentation.  
 
PRM176  
TRANSLATABILITY ASSESSMENT OF THE E-HEALTH IMPACT QUESTIONNAIRE 
(E-HIQ)  
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OBJECTIVES: Researchers at Oxford are developing a new self-reported assessment 
tool called the e-Health Impact Questionnaire (e-HIQ), which will be used to assess 
the impact of using health-related websites. A translatability assessment was 
performed on the draft items to establish whether they will be cross-culturally and 
linguistically valid should the questionnaire be translated in the future. METHODS: 
A concept elaboration document was produced in order to expand on the items 
within the e-HIQ; this was sent to medical translators in six countries who provided 
feedback on the translatability of the text from linguistic and cultural perspectives. 
The project manager reviewed the recommendations from each translator and 
suggested changes to the e-HIQ developer. This was followed by a teleconference 
between the developer and the project manager, during which the suggested 
changes were discussed and implemented to ensure the e-HIQ will be more easily 
translated in the future. Finally, a report detailing the whole process was created 
and submitted to the developer. RESULTS: Several changes were deemed necessary 
as a result of the translatability assessment. These changes included clarifying the 
intended tense of ‘I may face’ in order to avoid mistranslation, and changing the 
phrase ‘taking steps’ to ‘taking actions’, retaining the positive tone yet avoiding a 
literal translation. There were also three questions that, although distinct in 
English, have overlapping meanings when translated. The questions included the 
terms ‘solidarity’, ‘have a lot in common’ and ‘identify with people’. Although clear 
terms in English, many languages only have one way of saying all three terms and 
therefore a change was advised. CONCLUSIONS: This study highlights the 
importance of including a translatability assessment during the development of a 
measure as it enables developers to incorporate an international element into its 
development. In turn, this will enable an easier transition into various translations.  
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OBJECTIVES: While requirements for identifying cognitive interviewing 
respondents are not specifically outlined in the FDA Guidance for Industry 
Patient-Reported Outcome Measures, best practices dictate that respondents 
should be as closely representative of the study patient population as possible. 
For a questionnaire intended for a single patient population or a study with a 
single patient population, this concept is sufficient for determining criteria. On 
the other hand, some cases lend themselves to the use of multiple patient 
populations and more varied respondent criteria. METHODS: Past translation 
and linguistic validation projects that included cognitive interviewing of multiple 
patient populations were reviewed along with the process for determining their 
respective respondent criteria. RESULTS: For each project, the goal of cognitive 
interviewing was to determine patient understanding of concepts in the 
intended study population. As such, respondent inclusion criteria were 
developed to represent the intended study population as closely as possible. 
Criteria ranged from multiple cancer types, to multiple age groups, as well as 
caregiver and patient mixtures. In each case, more than one respondent of each 
sub-category was required in order to ensure sufficient feedback. CONCLUSIONS: 
Cognitive interviewing of a single patient population typically includes around 5 
respondents. With multiple populations, an increased total number of 
respondents are recommended. Balancing this with study budget and timeline 
restrictions presents a challenge. While exact representation of multiple patient 
populations may not be possible, development of a more broadly representative 
criteria that still includes multiple populations proves beneficial in ensuring that 
a questionnaire is fit for purpose.  
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DETERMINING THE CURRENT STATE-OF-PLAY FOR VARIANTS OF THE ‘SHORT 
FORM' HEALTH-RELATED QUALITY OF LIFE INSTRUMENT IN SPINAL CORD 
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OBJECTIVES: The SF-36 and SF-12 are generic health-related quality of life 
(HRQoL) instruments used in many areas of research, including spinal cord 
injury (SCI). Repeated concerns have been raised within the broader disability 
literature about the appropriateness of such measures for subjects with 
significant physical impairment, yet continued use is widespread. This 
systematic review provides a comprehensive descriptive overview of how the SCI 
research community has adopted variants of the ‘short form’ HRQoL 
instruments. METHODS: A systematic database and bibliographic search was 
conducted to identify SCI-related publications reporting outcome data using a 
HRQoL instrument related to the 36-item and 12-item short form measures (e.g. 
SF-36, SF-12, RAND-36, RAND-12, SF-6D). Three descriptive considerations 
formed the basis of the analysis; 1) the frequency of use across identified 
variants; 2) the degree to which instruments have been administered as partial 
measures (i.e. selective use of items or domains); and 3) a summary of data 
collection methodology. RESULTS: One hundred seventy-four articles met the 
selection criteria. In total, 9 variants were identified; the SF-36 was the most 
widely used complete measure (n=76), followed by the SF-12 (n=24), SF-6D (n=4), 
RAND-36 (n=1), and VR-36 (n=2). Partial use of instruments was common (n=54); 
some studies identified limitations regarding the Physical Functioning scale and 
tested modified measures (n=13), such as the SF-36E and the SF-36WW. Data 
collection methodology was often ambiguous or missing (n=65). CONCLUSIONS: 
The SF-36 is a common HRQoL measure within SCI research, despite oft-cited 
concerns regarding its measurement properties. Attempts to add, delete or 
modify items have resulted in a large number of variants, often with minimal 
supportive psychometric evidence. Using established generic outcome measures 
is appealing because it enables comparisons to be made across clinical 
specialties. However, the trade-off between comparability and context-specific 
validity requires further explicit consideration within the SCI research.  
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